Warning letter
Carib Supply of St. Croix, Inc.: warning letter of Dec 4, 2008
FDA warning letter 28826 · San Juan District Office
Key facts
| Reference number | 28826 |
|---|---|
| Company | Carib Supply of St. Croix, Inc. |
| Subject | CGMP Manufacture, Processing, Packing or Holding of Human Drugs/Adulterated |
| Issue date | Dec 4, 2008 |
| Posted date | Dec 4, 2008 |
| Issuing office | San Juan District Office |
| Product type | Drugs |
| CFR sections cited | 211.130, 211.22(a), 211.22(d), 211.100(b), 211.125(a), 211.160(b), 211.165(a), 211.188(b), 211.198(a) |
| Inspection city | St Croix |
| Inspection ZIP | 00822 |
| Inspection start date | Jun 26, 2007 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: